FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and medicine, and concerns a pancreas protector which contains a combination of a blood glucose decreasing drug not stimulating insulin secretion and a compound presented by formula (1), where the compound of formula (1) represents 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile or 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile exhibiting higher efficacy.
EFFECT: improved efficacy of the preparation.
15 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION AND TREATMENT AND RELATED COMPLICATION | 1996 |
|
RU2327455C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2323004C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2198682C2 |
| METHODS FOR PROPHYLAXIS AND TREATMENT, APPLICATION OF AGENT TO ENHANCE INSULIN SUSCEPTIBILITY | 2003 |
|
RU2286148C2 |
| THERAPEUTIC AGENT CONTAINING COMBINED USE OF COMBINATION OF DPP-IV INHIBITOR AND OTHER THERAPEUTIC AGENT FOR TREATING DIABETES | 2009 |
|
RU2523552C2 |
| COMBINED THERAPY WITH GPR119 AGONISTS AND DPP-4 INHIBITORS | 2020 |
|
RU2818562C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND RELATED METABOLIC DISEASES | 2021 |
|
RU2809286C1 |
| PHARMACEUTICAL COMPOSITION OF STATINS WITH PREBIOTIC FOR THERAPY OF HYPERCHOLESTEREMIA AND HYPERLIPIDEMIA | 2014 |
|
RU2591079C2 |
| PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER | 2011 |
|
RU2619215C2 |
| OXADIAZOLIDINONE COMPOUND | 2007 |
|
RU2440994C2 |
